In review: the life sciences regulatory regime in United Kingdom

This article reviews the essential regulatory considerations surrounding medicines and medical devices in United Kingdom, including clinical trials and marketing authorisations.

Related Keywords

United Kingdom ,Northern Ireland ,Craigavon ,Great Britain ,British , ,Association Of The British Pharmaceutical Industry ,Un Convention On Psychotropic Substances ,Organisation For Economic ,Un Single Convention On Narcotic Drugs ,European Commission ,Prescription Medicines Code Of Practice Authority ,Association Of British Healthcare Industries ,European Federation Of Pharmaceutical Industries ,National Health Service ,Home Office ,Property Office ,Enforcement Division ,European Union ,Good Laboratory Practice Regulations ,Complaints Adjudication Panel ,Borderline Section ,Scientific Procedures ,Economic Co Operation ,Human Use ,Clinical Trials ,Clinical Trial Regulations ,European Economic Area ,United Kingdom Manufacturing ,Import Authorisation ,Qualified Person ,British Pharmaceutical Industry ,Clinical Trial Compensation ,Medical Devices ,Medicines Regulations ,Medicines Scheme ,Medical Devices Regulations ,Northern Ireland Protocol ,Concerned Member State Medical ,Devices Regulation ,Medicine Regulations ,Intellectual Property Office ,Patents Act ,Brexit Transfer ,Responsible Person ,Blue Guide ,Pharmaceutical Industry ,Prescription Medicines Code ,Practice Authority ,European Federation ,Pharmaceutical Industries ,Associations Code ,United Kingdom Registered ,British Healthcare Industries ,Business Practice ,Vitro Diagnostic Medical Devices Regulation ,Drugs Act ,Drugs Regulations ,Narcotic Drugs ,Psychotropic Substances ,Medical Devices Act ,Law ,Lawyers ,Legal ,Aw Firms ,Aw Updates ,Egal Updates ,Egal Developments ,Aw Developments ,Egal Newsletters ,Egal Current Awareness ,Deals ,Egal Advisers ,Egal Advisors ,Egal Directory ,Ealthcare Amp Life Sciences ,